Ruthigen Overview

  • Year Founded
  • 2013

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 10

Employees

  • Latest Deal Type
  • M&A

  • Financing Rounds
  • 3

  • Investments
  • 1

Ruthigen General Information

Description

Pulmatrix Inc is a clinical stage biotechnology company. The company is focused on the discovery and development of novel inhaled therapeutic products intended to prevent and treat respiratory diseases and infections with significant unmet medical needs. Pulmatrix designs and develops inhaled therapeutic products based on its proprietary dry powder delivery technology, iSPERSE (inhaled Small Particles Easily Respirable and Emitted), which enables delivery of small or large molecule drugs to the lungs by inhalation for local or systemic applications. The iSPERSE powders are engineered to be small, dense particles with dispersibility and delivery to airways.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Corporate Office
  • 2455 Bennett Valley Road
  • Suite C116
  • Santa Rosa, CA 95404
  • United States
+1 (707)
Primary Industry
Drug Delivery
Other Industries
Drug Discovery
Pharmaceuticals
Acquirer
Pulmatrix
Vertical(s)
Life Sciences
Corporate Office
  • 2455 Bennett Valley Road
  • Suite C116
  • Santa Rosa, CA 95404
  • United States
+1 (707)

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Ruthigen Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Ruthigen‘s full profile, request access.

Request a free trial

Ruthigen Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Ruthigen Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Ruthigen‘s full profile, request access.

Request a free trial

Ruthigen Acquisitions (1)

Ruthigen’s most recent deal was a Reverse Merger with Pulmatrix. The deal was made on 15-Jun-2015.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Pulmatrix 15-Jun-2015 Reverse Merger Biotechnology
To view Ruthigen’s complete acquisitions history, request access »

Ruthigen Affiliates

Subsidiaries (1)

Name Industry Location Year Founded
Pulmatrix Framingham, MA 2003

Ruthigen FAQs

  • When was Ruthigen founded?

    Ruthigen was founded in 2013.

  • Where is Ruthigen headquartered?

    Ruthigen is headquartered in Santa Rosa, CA.

  • What is the size of Ruthigen?

    Ruthigen has 10 total employees.

  • What industry is Ruthigen in?

    Ruthigen’s primary industry is Drug Delivery.

  • Is Ruthigen a private or public company?

    Ruthigen is a Private company.

  • What is the current valuation of Ruthigen?

    The current valuation of Ruthigen is .

  • What is Ruthigen’s current revenue?

    The current revenue for Ruthigen is .

  • How much funding has Ruthigen raised over time?

    Ruthigen has raised $17.7M.

  • Who are Ruthigen’s investors?

    Sonoma Pharmaceuticals has invested in Ruthigen.

  • When was Ruthigen acquired?

    Ruthigen was acquired on 15-Jun-2015.

  • Who acquired Ruthigen?

    Ruthigen was acquired by Pulmatrix.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »